Prime Insights

Can bid data help boost medicine-related Star ratings?

Prime research decodes top Stars-related adherence predictors by category

Prime explores the top predictors of future adherence for three key Star ratings drug categories — high blood pressure, high cholesterol and diabetes — based on a recent study of more than 1.1 million Medicare members.

Top adherence predictors by category

Section divider

    Recent insights

Aug. 24, 2016 | Patrick Gleason, PharmD, FCCP, BCPS

Can big data help boost medicine-related Star ratings?

Prime performs adherence predictive modeling, using big data, to provide evidence-based recommendations to drive higher ratings for Star-related drug categories. 

Top predictors of adherence


Aug. 2 2016 | Jonathan Gavras, MD, FCCP

The CREATES Act: A viable solution for more affordable prescription drug choices

Lawmakers are fighting for more affordable prescription drug choices for families. The CREATES Act can pave the way, and Prime Therapeutics is on board.

How the CREATES Act can help


July 20, 2016 | Cathy Starner, PharmD, BCPS

America’s opioid epidemic: Part 5 — the future of safer opioid use

The opioid crisis is staggering, but steps are being taken in the right direction. What will tomorrow hold for safer opioid use?

Important work being done on the opioid front


July 12, 2016 | Cathy Starner, PharmD, BCPS

America’s opioid epidemic: Part 4 — fighting overuse through legislation, advocacy and political action

Solving the opioid crisis goes beyond the private sector. To drive meaningful change, health care, government and industry groups all have to work together.  

Evidence-based policies that could help combat the crisis


July 8, 2016 | Cathy Starner

America’s opioid epidemic: Part 3 — strategies for curbing abuse

Combating the opioid crisis requires a full set of tools — and proof that they work. See how the research stacks up. 

Strategies to keep members safe and control the total cost of care

Section divider